Usefulness of inflammatory and haemostatic markers to predict short-term risk for death in middle-aged ischaemic stroke patients

被引:33
作者
Rallidis, L. S. [1 ]
Vikelis, M. [2 ]
Panagiotakos, D. B. [3 ]
Liakos, G. K. [4 ]
Krania, E. [2 ]
Kremastinos, D. T. [1 ]
机构
[1] Univ Gen Hosp Attikon, Dept Cardiol 2, Athens, Greece
[2] Athens Naval Hosp, Dept Neurol, Athens, Greece
[3] Harokopio Univ, Dept Nutr Dietet, Athens, Greece
[4] Gen Hosp Nikea, Biochem Lab, Piraeus, Greece
来源
ACTA NEUROLOGICA SCANDINAVICA | 2008年 / 117卷 / 06期
关键词
D-dimer; fibrinogen; inflammatory markers; ischaemic stroke; mortality;
D O I
10.1111/j.1600-0404.2007.00971.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objectives - There is increasing evidence that inflammation and hypercoagulability play an important role in the pathophysiology of acute ischaemic stroke. We examined the in-hospital prognostic value on mortality of C-reactive protein (CRP), tumour necrosis factor-alpha (TNF-alpha), fibrinogen and D-dimer in middle-aged ischaemic stroke patients. Materials and methods - We recruited 231 consecutive patients < 66 years with acute ischaemic stroke. CRP, TNF-alpha, fibrinogen and D-dimer levels were determined within 12 h from admission. Results - Fifteen (6.5%) patients died during hospitalization. CRP, fibrinogen and D-dimer levels were significantly higher in patients who died compared with those who survived but only CRP and fibrinogen were independently associated with death, after adjusting for various confounding factors. For 1 mg/l increase in CRP there was a 20% higher risk of dying while for 10 mg/dl increase in fibrinogen the additive risk was 18%. CRP levels > 18 mg/l and fibrinogen levels > 490 mg/dl were the optimal points that discriminated those who died from the rest. Conclusions - CRP and fibrinogen levels can predict independently the risk of early death in middle-aged ischaemic stroke patients emphasizing the role of inflammation and coagulation in the evolution of ischaemic stroke.
引用
收藏
页码:415 / 420
页数:6
相关论文
共 36 条
[1]   C-reactive protein predicts further ischemic events in first-ever transient ischemic attack or stroke patients with intracranial large-artery occlusive disease [J].
Arenillas, JF ;
Alvarez-Sabín, J ;
Molina, CA ;
Chacón, P ;
Montaner, J ;
Rovira, A ;
Ibarra, B ;
Quintana, M .
STROKE, 2003, 34 (10) :2463-2468
[2]   Systemic inflammatory response depends on initial stroke severity but is attenuated by successful thrombolysis [J].
Audebert, HJ ;
Rott, MM ;
Eck, T ;
Haberl, RL .
STROKE, 2004, 35 (09) :2128-2133
[3]   Hemostatic function and progressing ischemic stroke - D-dimer predicts early clinical progression [J].
Barber, M ;
Langhorne, P ;
Rumley, A ;
Lowe, GDO ;
Stott, DJ .
STROKE, 2004, 35 (06) :1421-1425
[4]   Tumor necrosis factor-alpha - A mediator of focal ischemic brain injury [J].
Barone, FC ;
Arvin, B ;
White, RF ;
Miller, A ;
Webb, CL ;
Willette, RN ;
Lysko, PG ;
Feuerstein, GZ .
STROKE, 1997, 28 (06) :1233-1244
[5]   C-reactive protein and other inflammatory risk markers in acute coronary syndromes [J].
Blake, GJ ;
Ridker, PM .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (04) :37S-42S
[6]   C-reactive protein (CRP) in cerebro-vascular events [J].
Canova, CR ;
Courtin, C ;
Reinhart, WH .
ATHEROSCLEROSIS, 1999, 147 (01) :49-53
[7]   Role of inflammation in stroke and atherothrombosis [J].
Chamorro, A .
CEREBROVASCULAR DISEASES, 2004, 17 :1-5
[8]   Stroke in young adults: The role of paradoxical embolism [J].
Chant, H ;
McCollum, C .
THROMBOSIS AND HAEMOSTASIS, 2001, 85 (01) :22-29
[9]  
CLAUSS A., 1957, ACTA HAEMATOL, V17, P237
[10]   Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality - An individual participant meta-analysis [J].
Danesh, J ;
Lewington, S ;
Thompson, SG ;
Lowe, GDO ;
Collins, R .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (14) :1799-1809